East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Saxagliptin + Metformin
Kombiglyze
Not routinely available
SMC (929/13)
29/03/2023

Indication

In combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in adult patients aged 18 years and older with type 2 diabetes mellitus when the maximally tolerated dose of both metformin and the sulphonylurea does not provide ade...

In combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in adult patients aged 18 years and older with type 2 diabetes mellitus when the maximally tolerated dose of both metformin and the sulphonylurea does not provide adequate glycaemic control.

Therapeutic Area

Endocrine system

Status Description

Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines

Formulation

2.5mg/850mg and 2.5mg/1000mg filmcoated tablets

Comments

-

Link to Advice

929/13

Advice Published

13/01/2014

SMC Submission Type

Abbreviated

SMC Status

Accepted